Related Experiment Video
Updated: Aug 30, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Renal therapeutics: patent highlights January to June 2003
1HM Pharma Consultancy, Enenkelstrasse 28/32, A-1160 Wien, Austria. office@hmpharmacon.com
Abstract:
Drug-related patents with relevance to renal therapy that were published during the first half of 2003 were identified by searching Current Drugs' Patent fast-alert, evaluated for their relevance, and the most potentially significant of these documents are discussed in this review. Of the 19 documents that are analyzed in depth in this review, two related to renal cell carcinoma, three each to diabetic nephropathy, renal failure and/or allograft preservation or fibrosis, and four to inhibitors of angiotensin-converting enzyme or dipeptidylpeptidase IV, while only two identified potentially novel drug targets for renal therapy. The low number of patents with direct and substantial relevance for renal therapies indicates that kidney diseases are receiving relatively little attention from drug developers, in spite of their substantial impact on public health.
Related Concept Videos
Renal Drug Excretion: Tubular Secretion
Renal Drug Excretion: Tubular Reabsorption
Renal Drug Excretion: Overview
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
Therapeutic Index
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Drug Elimination by Renal Route: Tubular Reabsorption
